Product Details
Product Name:
SRI-011381 |
CAS No.:
1629138-41-5 |
Purity:
98.64% |
Supply Ability:
10g |
Release date:
2024/11/14 |
Product Introduction
Bioactivity
名稱 | SRI-011381 |
描述 | SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 55 mg/mL (166.93 mM)
|
關鍵字 | SRI-011381 | Transforming growth factor beta | inhibit | multiple | neuroprotective | NALP3 | collagen-1 | SRI011381 | TGF-β | sclerosis | Inhibitor | SRI 011381 | α-SMA | TGF-beta/Smad |
相關產(chǎn)品 | Monocrotaline | SB-431542 | DMH-1 | RepSox | Chromenone 1 | LY-364947 | BMP signaling agonist sb4 | Pirfenidone | A 83-01 | Galunisertib | Alantolactone | Pentabromophenol |
相關庫 | 細胞重編程化合物庫 | 經(jīng)典已知活性庫 | 神經(jīng)退行性疾病化合物庫 | 抗卵巢癌化合物庫 | 神經(jīng)保護化合物庫 | 抗心血管疾病化合物庫 | 干細胞分化化合物庫 | 已知活性化合物庫 | 抗肝癌化合物庫 | TGF-β/Smad靶點化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:883956-47-6
$35.00 / 1mg
-
CAS:2322245-42-9
$51.00 / 1mg
-
CAS:2086809-58-5
$84.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$1520.00/25mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |
|
$52.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 |